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Surgical Residents and PhD 
Candidate Make Significant 
Contributions to Ongoing Adult 
Stem Cell Research
Paul DiMuzio, MD, directs the Vascular 
Tissue Engineering Laboratory within 
the Department of Surgery at Thomas 
Jefferson University. “The overall goal  
of our research is to develop a durable 
blood vessel replacement for those 
patients who do not have enough of their 
own tissues for heart or leg bypass surgery 
or hemodialysis access. We combine 
tissue engineering techniques with adult 
stem cell technology to make such a 
graft,” explains Dr. DiMuzio. Specifically, 
the researchers repopulate a cadaver 
blood vessel with the patient’s own stem 
cells (isolated from their fat) that have 
been changed into endothelial cells.
Recent work has focused on the effects 
of fluid-induced shear stress and genetic 
manipulation on the differentiation 
of the stem cells. The investigators are 
developing methods to more effectively 
change the stem cells into endothelial 
cells by altering their environment 
as well as their genetic composition. 
The following research trainees have 
investigated these issues under the 
mentorship of Dr. DiMuzio:
During his research year, Eric Hager, 
MD, a 4th year resident, studied 
how fluid flow influences stem cell 
adhesion to the vascular graft. Dr. 
Hager successfully demonstrated that 
shear stress improves the ability of stem 
cells to adhere to grafts secondary to 
up-regulation of integrin expression 
(proteins on the cell surface necessary for 
cell adhesion). Dr. Hager presented this 
work at the Society of Vascular Surgery’s 
National Annual meeting in June, 2008 
in San Diego—a presentation highlighted 
in a press release at the meeting.
Neil Moudgill, MD, another 4th year 
resident, evaluated the role of shear 
stress on stem cell differentiation. He 
found that shear stress significantly 
up-regulated certain endothelial cell-
specific proteins due to stimulation of a 
specific differentiating pathway. His work 
was presented at the Annual Resident 
Research Competition at the University 
of Rochester in April, 2008. Neil’s 
presentation was picked as one of three 
winners in this national competition.
While surgical residents spend one year 
in the research laboratory, Stephen 
McIlhenny, BS, is currently in his fourth 
year as a PhD candidate in Jefferson’s 
Tissue Engineering and Regenerative 
Medicine (T.E.R.M.) program. Stephen 
designed a novel vascular bioreactor 
in which the stem cell vascular graft is 
created and cultured. He successfully 
demonstrated that a gradual increase in 
shear stress was critical to the retention 
of stem cells on the graft, work that 
he presented at the 2007 Biomedical 
Engineering Society (BMES) Annual 
Meeting in Los Angeles.
Additionally, Stephen recently genetically 
manipulated the stem cells to express 
endothelial nitric oxide synthase (eNOS), 
a gene critical for function of endothelial 
cells. Most importantly, Steven 
demonstrated that this manipulation has 
led to the release nitric oxide (NO), a 
molecule critical to blood vessel function 
and health. Steven’s research on stem cell 
eNOS transfection will be presented at 
the Tissue Engineering and Regenerative 
Medicine International Society 
(TERMIS) meeting in December 2008.
Under the sponsorship of Thomas 
Tulenko, PhD, Director of the Division 
of Research, and Dr. DiMuzio, Stephen 
has been granted an American Heart 
Association Pre-doctoral Fellowship.
Tanya Wynder,
MSN, CRNP, NP-C 
Tanya Wynder is one of two  
Transplant Surgery Nurse Practitio-
ners in the Department of Surgery. 
She came to Jefferson in April 2006 
from Temple University Hospital. 
Can you describe your role as a 
Transplant Nurse Practitioner?
I am deeply involved in patients’ 
pre- and post-operative care, 
including patient assessment, history, 
and physicals. I provide direct care 
immediately after surgery for patients 
at the hospital as well as outpatients  
at the clinic. In 2007, we transplanted 
63 livers, 47 kidneys, and 3  
pancreases at Jefferson.
What’s the best part of your job?
Well, there are really two things.  
First are the people I work with.  
Here, nurse practitioners are truly 
valued and have an important role. 
That goes a long way in my job 
satisfaction. Second is getting to 
know pre-transplant patients and 
then to see the real transformation 
the surgery brings to their lives. For 
example, kidney recipients no longer 
need dialysis 4 hours a day for 3 days 
a week—that’s more than 600 hours a 
year that they get back. Imagine what 
you would do with an extra 600 hours 
a year!
How did you become interested in 
transplant surgery?
When I was younger, my father 
needed a heart transplant. He wasn’t 
patient. One day he said “enough”—
he left the hospital and died the next 
day at home. While I am first and 
foremost a professional, I think with 
that experience I bring another layer 
of compassion and understanding to 
my patients and their families.
Stephen McIlhenny, PhD candidate with Drs. Eric Hager and Neil Moudgill.
For an appointment with a Jefferson Surgeon, call 1-800-JEFF-NOW
The overall goal of our 
research is to develop 
a durable blood vessel 
replacement for those 
patients who do not have 
enough of their  
own tissues.
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